Balyasny Asset Management LLC Bio Techne Corp Transaction History

Balyasny Asset Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$73.76 - $85.98 $8.36 Million - $9.75 Million	-113,384 Reduced 21.19%	421,721 $34.4 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $38 Million - $46 Million	531,171 Added 13502.06%	535,105 $39.7 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $317,355 - $1.39 Million	3,934 New	3,934 $326,000
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $25.3 Million - $35.2 Million	78,390 New	78,390 $27.2 Million
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $894,779 - $1.17 Million	-2,844 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $702,183 - $915,398	2,844 New	2,844 $903,000
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $1.18 Million - $1.62 Million	-7,318 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $1.39 Million - $1.63 Million	7,318 New	7,318 $1.61 Million
Q1 2018 May 15, 2018	SELL	$131.46 - $151.04 $1.93 Million - $2.22 Million	-14,713 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$121.17 - $134.75 $1.19 Million - $1.32 Million	9,833 Added 201.5%	14,713 $1.91 Million
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $554,319 - $604,046	4,880	4,880 $590,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.